• Ertugliflozin (PF-04971729) Research Workflows

  2026-08-12

  Ertugliflozin (PF-04971729) combines highly selective SGLT2 biology with a practical workflow for renal glucose transport, diabetes mellitus research, and exploratory brain insulin-signaling studies. This guide translates the reference rat study into assay-ready steps, controls, and troubleshooting decisions without overstating clinical or central nervous system evidence.

• (R,S)-Anatabine for Reliable Cell Assays

  2026-08-12

  This scenario-based guide explains how SKU C4859, (R,S)-Anatabine, can be incorporated into cell viability, proliferation, and amyloid-processing workflows without confusing pathway activity with nonspecific cytotoxicity. It covers model selection, solvent control, protocol preparation, data interpretation, and practical supplier evaluation.

• CCR7–Notch1 Crosstalk Drives Mammary Cancer Stemness

  2026-08-11

  Boyle et al. showed that CCR7 and Notch1 form a functional signaling circuit that sustains stem-like properties in MMTV-PyMT mammary cancer cells. The work provides a mechanistic basis for considering coordinated disruption of both axes, while its primary-cell mouse model also defines important limits for clinical translation.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-11

  The 2025 reference study identifies naturally occurring angiotensin fragments as modulators of SARS-CoV-2 spike-protein binding to host receptors, with the strongest effects associated with shorter peptides and tyrosine modification. Its antibody-based binding design provides a useful framework for connecting renin-angiotensin system research with viral-receptor biology while highlighting the need for cell-based and in vivo validation.

• NBC19: NLRP3 Inflammasome Inhibitor Workflows

  2026-08-10

  NBC19 enables controlled, dose-responsive interrogation of NLRP3-driven IL-1β release in differentiated THP1 cells. This practical guide connects benchmark Nigericin and ATP assays with cancer-inflammation models, including exploratory studies of circulating macrophage-like giant cells.

• Sitagliptin Phosphate Monohydrate in Translation

  2026-08-09

  Sitagliptin phosphate monohydrate offers a precise way to interrogate DPP-4, incretin biology, and metabolic state. By connecting peptide preservation with new evidence on intestinal stretch, this article outlines a translational framework for stronger metabolic and vascular research designs.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-08-08

  Breen and colleagues developed a genetically engineered, drug-sensitized yeast platform that detects TOR pathway inhibitors at substantially lower concentrations than wild-type yeast. The system distinguishes TOR-dependent growth effects and provides a practical screening framework, while its negative result for Canagliflozin illustrates why pathway-specific validation is essential in metabolic research.

• FLAG tag Peptide (DYKDDDDK): Uses & Limits

  2026-08-07

  The FLAG tag Peptide is the eight-residue DYKDDDDK epitope used for recombinant protein detection and affinity purification. Its defined composition, high reported solubility, and compatibility with anti-FLAG M1 and M2 affinity resin elution support reproducible workflows, while its inability to elute 3X FLAG fusions defines an important boundary.

• Recombinant Human Oncostatin M: Mechanistic Insights & Preci

  2026-08-07

  Explore how Recombinant Human Oncostatin M (rh-Oncostatin M) enables advanced, mechanistically informed cytokine stimulation of fibroblast proliferation and beyond. This article uniquely bridges molecular action, protocol precision, and the latest reference findings for next-generation research.

• AG-221 (Enasidenib): Deep Mechanistic Insights & Practical P

  2026-08-06

  Explore the advanced mechanism and practical assay considerations of AG-221 (Enasidenib) in acute myeloid leukemia research. This article delivers a unique, science-driven perspective on metabolic rewiring, resistance, and optimal experimental use, setting it apart from existing content.

• SMAD3 Inhibition Lowers ADAMTS-5 via miRNA-140 in Early Oste

  2026-08-06

  Xiang et al. demonstrate that pharmacological inhibition of SMAD3 suppresses ADAMTS-5 expression in early osteoarthritis, likely through upregulation of miRNA-140. This mechanistic insight offers a targeted approach for dissecting TGF-β/Smad signaling in cartilage degeneration models and highlights new avenues for fibrosis research.

• PF-04971729 (Ertugliflozin): Advanced Workflows in Diabetes

  2026-08-05

  Ertugliflozin (PF-04971729) redefines experimental precision in diabetes mellitus and neurodegeneration research. This guide delivers actionable protocol enhancements, real-world troubleshooting, and novel use-cases that set APExBIO's high-purity offering apart for SGLT2-mediated glucose transport studies.

• Anagliptin Induces Vasorelaxation via Kv Channel and SERCA A

  2026-08-05

  The referenced Acta Diabetologica study demonstrates that anagliptin (SK-0403), a DPP-4 inhibitor, directly induces vasorelaxation in rabbit aorta by activating voltage-dependent K+ (Kv) channels and the SERCA pump. These findings clarify the vascular actions of anagliptin, informing research on cardiovascular safety in diabetes therapies and supporting protocol development for vascular pharmacology studies.

• Protein A/G Magnetic Beads: Accelerating Translational Prote

  2026-08-04

  Explore how Protein A/G Magnetic Beads empower translational researchers to dissect complex protein interactions in disease models, with mechanistic insight and actionable strategies for immunoprecipitation-based discovery. Bridging the latest molecular findings in degenerative disease with advanced bead technology, this article provides protocol guidance, competitive context, and a forward-looking perspective on precision affinity workflows.

• SP2509 as a Lysine-Specific Demethylase 1 Antagonist: Applie

  2026-08-04

  SP2509 empowers researchers to interrogate cancer epigenetics with precision, offering robust, reproducible modulation of LSD1 activity in AML and beyond. This guide delivers step-by-step protocols, protocol-optimizing insights, and troubleshooting support for leveraging SP2509’s full potential in applied bench research.

16111 records 1/1075 page Next 12345 下5页 Last page